Skip to main content
Clinical Trials/NCT01722565
NCT01722565CompletedPhase 4

Randomized, Controlled, Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection

Corporacion Parc Tauli2 sites in 1 country32 target enrollmentStarted: January 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
32
Locations
2
Primary Endpoint
The reduction in the incidence of Parastomal Hernia after the mesh placement

Study Overview

Brief Summary

Introduction: parastomal hernia (PH) is a frequent complication after an ostomy, despite the many prevention and treatment techniques that have been described. Since the introduction of laparoscopy, the frequency of PH is even higher than in open surgery. This type of hernia remains a surgical problem of considerable importance, requiring significant consumption of public health and economic resources, and representing a major alteration of the quality of life of these patients.

Objective: to evaluate the effectiveness of the insertion of a prosthesis to prevent PH in elective surgery for laparoscopic abdominoperineal resection.

Methodology: prospective, multidisciplinary, multi-center randomized controlled study. Control group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection. Study group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25). Sample size was calculated based on a proportion of parastomal hernia of 65% in the control group and 15% in the study group. With an α risk =0.05 and 1- β= 0.8, 28 patients are required, 14 per group. Estimating a drop-out rate of 10%, the final number will be 32 patients. The efficacy will be evaluated clinically at six months and abdominal CT will be performed at 12 months along with another clinical evaluation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients of either sex intervened electively for colorectal surgery (rectal cancer) in whom definitive colostomy is indicated after laparoscopic abdominoperineal amputation.
  • Life expectancy above 12 months

Exclusion Criteria

  • - Patients with allergy or intolerance of the compounds in the mesh
  • Carriers of prosthetic meshes in the area of the ostomy
  • Patients electively intervened for colorectal surgery (neo de reco) in whom definitive colostomy is indicated after abdominoperineal amputation but not via a laparoscopic approach.
  • Cirrhotic patients
  • Patients with life expectancy below 12 months due to underlying disease

Arms & Interventions

Control Group

No Intervention

Patients receiving conventional sigmoid end colostomy by laparoscopic procedure, without mesh

Mesh Group

Experimental

Patients receiving conventional sigmoid end colostomy plus a preperitoneal lightweight mesh Physiomesh® by laparoscopic procedure

Intervention: laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25) (Procedure)

Outcomes

Primary Outcomes

The reduction in the incidence of Parastomal Hernia after the mesh placement

Time Frame: 12 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Corporacion Parc Tauli
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xavier Serra-Aracil

Medical Doctor

Corporacion Parc Tauli

Study Sites (2)

Loading locations...

Similar Trials